Announcements Trials
Browse Landscape

Phase

Phase 3 7Phase 4 6Phase 2 3Phase 1 2

Status

Completed 3

Sponsor Class

INDIV 2INDUSTRY 1

Study Type

Interventional 3

Sponsor

Conditions

Lipoma 2Dupuytren Contracture 1

Interventions

Cisplatin 1514Carboplatin 1416Cyclophosphamide 1359Gemcitabine 1235Bevacizumab 1223Paclitaxel 1210Radiotherapy 1173Docetaxel 1079pembrolizumab 1026Oxaliplatin 934Capecitabine 898Fluorouracil 832Rituximab 729Doxorubicin 683Nivolumab 679Dexamethasone 665Etoposide 660Irinotecan 622Leucovorin 574Pemetrexed 508Drug Therapy 491Cetuximab 481Trastuzumab 467Cytarabine 466Magnetic Resonance Spectroscopy 457Filgrastim 446Prednisone 432Lenalidomide 409Specimen Handling 407Temozolomide 400

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 2 × Microbial Collagenase × Clear all
NCT02193828 2017-10-05

Phase 2a Dose-Ranging Study to Evaluate Safety and Effectiveness of AA4500 in Treatment of Dupuytren's Disease Nodules

Endo Pharmaceuticals

Phase 2 Completed
76 enrolled 17 charts

Dupuytren Contracture

NCT02249052 2017-02-23

Double Blind Study to Evaluate the Efficacy of Collagenase Histolyticum in the Treatment of Lipoma

Gerut, Zachary, M.D.

Phase 2 Completed
19 enrolled 11 charts

Lipoma

NCT01613313 2016-10-06

A Dose Escalation Study Using Collagenase Clostridium Histolyticum in the Treatment of Lipoma

Gerut, Zachary, M.D.

Phase 2 Completed
14 enrolled 8 charts

Lipoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡